These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16079911)

  • 1. Fhl2 deficiency results in osteopenia due to decreased activity of osteoblasts.
    Günther T; Poli C; Müller JM; Catala-Lehnen P; Schinke T; Yin N; Vomstein S; Amling M; Schüle R
    EMBO J; 2005 Sep; 24(17):3049-56. PubMed ID: 16079911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four and half lim protein 2 (FHL2) stimulates osteoblast differentiation.
    Lai CF; Bai S; Uthgenannt BA; Halstead LR; McLoughlin P; Schafer BW; Chu PH; Chen J; Otey CA; Cao X; Cheng SL
    J Bone Miner Res; 2006 Jan; 21(1):17-28. PubMed ID: 16355270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
    Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
    FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Core-binding factor beta interacts with Runx2 and is required for skeletal development.
    Yoshida CA; Furuichi T; Fujita T; Fukuyama R; Kanatani N; Kobayashi S; Satake M; Takada K; Komori T
    Nat Genet; 2002 Dec; 32(4):633-8. PubMed ID: 12434152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteopenia, decreased bone formation and impaired osteoblast development in Sox4 heterozygous mice.
    Nissen-Meyer LS; Jemtland R; Gautvik VT; Pedersen ME; Paro R; Fortunati D; Pierroz DD; Stadelmann VA; Reppe S; Reinholt FP; Del Fattore A; Rucci N; Teti A; Ferrari S; Gautvik KM
    J Cell Sci; 2007 Aug; 120(Pt 16):2785-95. PubMed ID: 17652162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of aryl hydrocarbon receptor activity by four and a half LIM domain 2.
    Kollara A; Brown TJ
    Int J Biochem Cell Biol; 2009 May; 41(5):1182-8. PubMed ID: 19015043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitous overexpression of Hey1 transcription factor leads to osteopenia and chondrocyte hypertrophy in bone.
    Salie R; Kneissel M; Vukevic M; Zamurovic N; Kramer I; Evans G; Gerwin N; Mueller M; Kinzel B; Susa M
    Bone; 2010 Mar; 46(3):680-94. PubMed ID: 19857617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four-and-a-half LIM domain protein 2 is a novel regulator of sphingosine 1-phosphate receptor 1 in CCL19-induced dendritic cell migration.
    König K; Diehl L; Rommerscheidt-Fuss U; Golletz C; Quast T; Kahl P; Kolanus W; Knolle P; Buettner R; Heukamp LC
    J Immunol; 2010 Aug; 185(3):1466-75. PubMed ID: 20592280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia.
    Li J; Sarosi I; Cattley RC; Pretorius J; Asuncion F; Grisanti M; Morony S; Adamu S; Geng Z; Qiu W; Kostenuik P; Lacey DL; Simonet WS; Bolon B; Qian X; Shalhoub V; Ominsky MS; Zhu Ke H; Li X; Richards WG
    Bone; 2006 Oct; 39(4):754-66. PubMed ID: 16730481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency in the LIM-only protein Fhl2 impairs skin wound healing.
    Wixler V; Hirner S; Müller JM; Gullotti L; Will C; Kirfel J; Günther T; Schneider H; Bosserhoff A; Schorle H; Park J; Schüle R; Buettner R
    J Cell Biol; 2007 Apr; 177(1):163-72. PubMed ID: 17420295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biological relevance of FHL2 in tumour cells and its role as a putative cancer target.
    Kleiber K; Strebhardt K; Martin BT
    Anticancer Res; 2007; 27(1A):55-61. PubMed ID: 17352216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective Runx2-II deficiency leads to low-turnover osteopenia in adult mice.
    Xiao Z; Awad HA; Liu S; Mahlios J; Zhang S; Guilak F; Mayo MS; Quarles LD
    Dev Biol; 2005 Jul; 283(2):345-56. PubMed ID: 15936013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis.
    Wang J; Yang Y; Xia HH; Gu Q; Lin MC; Jiang B; Peng Y; Li G; An X; Zhang Y; Zhuang Z; Zhang Z; Kung HF; Wong BC
    Gastroenterology; 2007 Mar; 132(3):1066-76. PubMed ID: 17383428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of Hand1 homodimer and Hand1-E12 heterodimer activity by the cofactor FHL2.
    Hill AA; Riley PR
    Mol Cell Biol; 2004 Nov; 24(22):9835-47. PubMed ID: 15509787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The four-and-a-half-LIM protein 2 (FHL2) is overexpressed in gliomas and associated with oncogenic activities.
    Li M; Wang J; Ng SS; Chan CY; Chen AC; Xia HP; Yew DT; Wong BC; Chen Z; Kung HF; Lin MC
    Glia; 2008 Sep; 56(12):1328-38. PubMed ID: 18615633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoblast-specific expression of MEF induces osteopenia through downregulation of osteoblastogenesis and upregulation of osteoclastogenesis.
    Seul KJ; Cho HS; Heo SH; Baek WY; Kim JE; Park EK; Choi JY; Ryoo HM; Cho JY
    J Bone Miner Res; 2011 Feb; 26(2):341-50. PubMed ID: 20715187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expression of fibroblast growth factor-2 causes defective bone mineralization and osteopenia in transgenic mice.
    Sobue T; Naganawa T; Xiao L; Okada Y; Tanaka Y; Ito M; Okimoto N; Nakamura T; Coffin JD; Hurley MM
    J Cell Biochem; 2005 May; 95(1):83-94. PubMed ID: 15723277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The suppressive effect of myeloid Elf-1-like factor (MEF) in osteogenic differentiation.
    Kim YJ; Kim BG; Lee SJ; Lee HK; Lee SH; Ryoo HM; Cho JY
    J Cell Physiol; 2007 Apr; 211(1):253-60. PubMed ID: 17167770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FIAT represses ATF4-mediated transcription to regulate bone mass in transgenic mice.
    Yu VW; Ambartsoumian G; Verlinden L; Moir JM; Prud'homme J; Gauthier C; Roughley PJ; St-Arnaud R
    J Cell Biol; 2005 May; 169(4):591-601. PubMed ID: 15911876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone-targeted overexpression of Bcl-2 increases osteoblast adhesion and differentiation and inhibits mineralization in vitro.
    Zhang W; Pantschenko AG; McCarthy MB; Gronowicz G
    Calcif Tissue Int; 2007 Feb; 80(2):111-22. PubMed ID: 17308993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.